Elsewhere, in genome-wide CRISPR KO screening studies with the GeckOv2 library, E2F6 was upregulated in epidermal growth factor receptor (EGFR)-mutant U87 GBM cells expressing mutant EGFRvIII upon TMZ treatment [74]. The gene discussed is EGFR; the disease is glioblastoma.